SCHEMBL2636403

SCHEMBL2636403

COc1cc(/C=C/c2ccc(C(=O)O)cc2)ccc1C(OC)OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCL12 P48061 1/20 0.53
ABCG2 Q9UNQ0 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MKNK2 Q9HBH9 1/20 0.46
XDH P47989 1/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP1B1 Q16678 1/20 0.45
NPC1 O15118 2/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636406 1.00 CXCL12 (0.53) CXCL12ABCG2MEN1KMT2AMKNK2
SCHEMBL28048505 0.83 KMT2A (0.47) MEN1KMT2AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL4254456 0.82 ABCG2 (0.67) CXCL12ABCG2MEN1KMT2AKDM4E
SCHEMBL4254451 0.82 ABCG2 (0.67) CXCL12ABCG2MEN1KMT2AKDM4E
SCHEMBL5692902 0.80 CXCL12 (0.79) CXCL12ABCG2MEN1KMT2AXDH
SCHEMBL5692905 0.80 CXCL12 (0.79) CXCL12ABCG2MEN1KMT2AXDH
SCHEMBL5693342 0.78 PKM (0.61) CXCL12MEN1KMT2AMKNK2XDH
SCHEMBL5693344 0.78 PKM (0.61) CXCL12MEN1KMT2AMKNK2XDH
SCHEMBL2636878 0.77 CXCL12 (0.56) CXCL12ABCG2MEN1KMT2AMKNK2
SCHEMBL4576554 0.77 CXCL12 (0.52) CXCL12ABCG2MEN1KMT2AMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2437792-B1 IMAGING OF MYELIN BASIC PROTEIN GEN ELECTRIC (US) 2015-10-21 EP disclosed
US-8617515-B2 Imaging of myelin basic protein GENERAL ELECTRIC COMPANY (US) 2013-12-31 US disclosed
EP-2437792-A2 IMAGING OF MYELIN BASIC PROTEIN General Electric Company (US) 2012-04-11 EP disclosed
WO-2010141704-A2 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 WO disclosed
US-20100310457-A1 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100310457-A1 IMAGING OF MYELIN BASIC PROTEIN MAG, PMP22, MYT1 CXCL12 2457/4885ABCG2 4452/4885MEN1 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.